Translate to...

Virologists select SARS-CoV-2 vaccine candidate for clinical trials

Virologists select SARS-CoV-2 vaccine candidate for clinical trials

Virologists at the Rega Institute at KU Leuven (Belgium) have developed a vaccine candidate that protects hamsters from infection with the SARS-CoV-2 coronavirus. Theirs is one of the first vaccine candidates that is proven to protect lab animals from infection. The team aims to start clinical trials next Winter. Their findings are pending peer review, but the researchers have already submitted their results to preprint server bioRxiv.